Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05183867 · ClinicalTrials.gov registry record · NA

Behavior, Biology and Well-Being Study

A NA study, sponsored by University of Wisconsin, Madison.

Completed
Registry status
NA
Development phase
1,157
Enrollment target

NCT05183867: Completed NA study, sponsored by University of Wisconsin, Madison.

NCT05183867 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 1,157 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (18% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05183867, a NA study, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
NA
Development phase
1,157 participants
Enrollment target

Study Summary

The central aim of this study is to test the efficacy of the Healthy Minds Program (HMP) app, an intervention designed to promote well-being. The investigators plan to conduct a randomized controlled trial (RCT) involving 1100 participants comparing 4-weeks of the HMP app with an active control (Psychoeducation \[HMP without meditation practice\]), and a waitlist control in a sample of United States adults with elevated depression symptoms.

Primary Outcome

The PHQ-8 is an 8-item questionnaire where participants report how often in the past 2 weeks they were bothered by specific problems. It is scored on a 4-point Likert scale where 0 = not at all to 3 = nearly every day. The total possible range of scores is 0-24 where higher scores indicate more depressive symptoms.

Interventions

  • DEVICE Healthy Minds Program

Trial Details

FieldValue
Enrollment Target 1,157 participants
Start Date 2022-03-24
Est. Completion 2024-07-15
Phase NA
University of Wisconsin, Madison

1,039 total trials

What the finished NCT05183867 record still lists

NCT05183867 is an interventional study that assigns participants to a tested intervention. Its 1,157 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (18% lower).

The record links to 0 conditions, and to 1 intervention - of which Healthy Minds Program is the first listed.

NCT05183867 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05183867 about?

NCT05183867 is a clinical study titled "Behavior, Biology and Well-Being Study". The central aim of this study is to test the efficacy of the Healthy Minds Program (HMP) app, an intervention designed to promote well-being. The investigators plan to conduct a randomized controlled trial (RCT) involving 1100 participants comparing 4-weeks of the HMP app with an active control (Psy...

What is the current status of trial NCT05183867?

This trial is currently completed. It is a NA study. The enrollment target is 1,157 participants. The study started on 2022-03-24. Estimated completion is 2024-07-15.

What interventions are being tested in trial NCT05183867?

The interventions under investigation include: Healthy Minds Program (DEVICE).

Who is sponsoring clinical trial NCT05183867?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05183867's enrollment target sits among peer trials

1,157 92nd of 2000 higher than 1,909 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04577599 · 1,160 participants · NA

    Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54

  • NCT07082738 · 1,160 participants · Phase 2

    A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

  • NCT04474301 · 1,152 participants

    Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic

  • NCT05564026 · 1,151 participants

    Molecular Epidemiology of Pediatric Germ Cell Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05183867, the US trial registry maintained by the National Library of Medicine. NCT05183867 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.